Here we describe the capability of this aptamer, as well as a second aptamer against EpCAM, as an alternative to current EpCAM antibodies for chromogenic staining of formalin-fixed paraffin-embedded tumor tissues. The gene discussed is EPCAM; the disease is neoplasm.